Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
Company profile
Website
CEO
Nassim Usman
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
743058741
Latest filings (excl ownership)
D/A
$2M in debt / options / securities to be acquired, sold $1.89M, 10 investors
13 Jul 15
D
$1M in debt / options / securities to be acquired, sold $1M, 10 investors
11 Jun 15
D
$5M in equity, sold $3.22M, 11 investors
3 Feb 15
D
$5.01M in equity / options, sold $5.01M, 18 investors
23 Apr 14
D
$800.01K in equity, sold $400K, 11 investors
20 Aug 13
D
$18.59M in equity, sold $13.41M, 21 investors
25 Sep 12
D
Exempt offering of security
8 Dec 08
REGDEX
Notice of sale of securities
17 Dec 07
REGDEX
Notice of sale of securities
17 Feb 06
REGDEX/A
Notice of sale of securities (amended)
21 Oct 04